Minireviews
Copyright ©The Author(s) 2015.
World J Hepatol. Mar 27, 2015; 7(3): 548-558
Published online Mar 27, 2015. doi: 10.4254/wjh.v7.i3.548
Table 2 Hepatitis C virus-associated mortality in hemodialysis patients: National surveys
National surveyRef.No. of HD patientsOutcomeRelative risk
Australia New Zealand Dialysis and Transplant RegistryScott et al[62]23046 (10-yr follow up)Independent and significant association between a HCV(+) and all-cause mortalityHR = 1.25 (95%CI: 1.07-1.46, P = 0.004)
National or regional dialysis registries of 10 Asia-Pacific countries/areas (Australia, New Zealand, Japan, China, Taiwan, Korea, Thailand, Hong-Kong, Malaysia, India)Johnson et al[63]173788Data available for Australia, New Zealand and JapanHR = 1.25 (95%CI: 1.07-1.46, P = 0.004)
Dialysis Outcomes and Practice Patterns Study (DOPPS) from the United States (in three continents: Europe, Japan, United States)Goodkin et al[64]206134a HCV(+) is an independent predictor of all-cause mortalityRR = 1.17 (P < 0.0159)
The Japanese cohortJapanese Society of Dialysis[65]76201a HCV(+) is an independent predictor of all-cause mortalityRR = 1.37 (95%CI: 1.15-1.62, P = 0.003)